Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Esophagus
Published in: Esophagus 1/2019

01-01-2019 | Original Article

Perioperative enteral supplementation with glutamine, fiber, and oligosaccharide reduces early postoperative surgical stress following esophagectomy for esophageal cancer

Authors: Tetsuya Abe, Takahiro Hosoi, Ryosuke Kawai, Norihisa Uemura, Eiji Higaki, Byonggu An, Jiro Kawakami, Takuya Saito, Yasuhiro Shimizu

Published in: Esophagus | Issue 1/2019

Login to get access

Abstract

Background

We clarified the effects of perioperative enteral supplementation with glutamine, fiber, and oligosaccharide (GFO) after an esophagectomy on preventing surgical stress.

Methods

Of 326 patients with esophageal cancer, 189 received GFO administration (GFO group) and 137 did not (control group). The propensity score matching method was used to identify 89 well-balanced pairs of patients to compare postoperative laboratory parameters and clinical and postoperative outcomes.

Results

The duration of the systemic inflammatory response syndrome (SIRS) was significantly shorter in the GFO group compared to the control group (p = 0.002). Moreover, the lymphocyte/neutrophil ratio (L/N ratio) had significantly recovered in the GFO group on postoperative day-3, and the CRP value was significantly lower in the GFO group than that in the control group on postoperative day-2.

Conclusions

Perioperative use of enteral supplementation with glutamine, fiber, and oligosaccharide likely contributes to a reduction in early surgical stress after an esophagectomy. These beneficial effects can bring about early recovery from postoperative immunosuppressive conditions after radical esophagectomy.
Literature
1.
Lerut T, Moons J, Coosemans W, et al. Postoperative complications after transthoracic esophagectomy for cancer of the esophagus and gastroesophageal junction are correlated with early cancer recurrence: role of systematic grading of complications using the modified Clavien classification. Ann Surg. 2009;250(5):798–807.CrossRefPubMed
2.
Matsubara T, Ueda M, Nagao N, et al. Surgical treatment for carcinoma of the thoracic esophagus with major involvement in the neck or upper mediastinum. J Surg Oncol. 1998;67(1):6–10.CrossRefPubMed
3.
Igaki H, Tachimori Y, Kato H. Improved survival for patients with upper and/or middle mediastinal lymph node metastasis of squamous cell carcinoma of the lower thoracic esophagus treated with 3-field dissection. Ann Surg. 2004;239(4):483–90.CrossRefPubMedPubMedCentral
4.
Sato N, Koeda K, Ikeda K, et al. Randomized study of the benefits of preoperative corticosteroid administration on the postoperative morbidity and cytokine response in patients undergoing surgery for esophageal cancer. Ann Surg. 2002;236(2):184–90.CrossRefPubMedPubMedCentral
5.
Kooguchi K, Kobayashi A, Kitamura Y, et al. Elevated expression of inducible nitric oxide synthase and inflammatory cytokines in the alveolar macrophages after esophagectomy. Crit Care Med. 2002;30(1):71–6.CrossRefPubMed
6.
van Sandick JW, Gisbertz SS, ten Berge IJ, et al. Immune responses and prediction of major infection in patients undergoing transhiatal or transthoracic esophagectomy for cancer. Ann Surg. 2003;237(1):35–43.CrossRefPubMedPubMedCentral
7.
Okamura A, Takeuchi H, Matsuda S, et al. Factors affecting cytokine change after esophagectomy for esophageal cancer. Ann Surg Oncol. 2015;22(9):3130–5.CrossRefPubMed
8.
Dabrowska AM, Slotwinski R. The immune response to surgery and infection. Central Eur J Immunol. 2014;39(4):532–7.CrossRef
9.
Kobayashi K, Koyama Y, Kosugi S, et al. Is early enteral nutrition better for postoperative course in esophageal cancer patients? Nutrients. 2013;5(9):3461–9.CrossRefPubMedPubMedCentral
10.
Palanivelu C, Prakash A, Senthilkumar R, et al. Minimally invasive esophagectomy: thoracoscopic mobilization of the esophagus and mediastinal lymphadenectomy in prone position—experience of 130 patients. J Am Coll Surg. 2006;203(1):7–16.CrossRefPubMed
11.
Biere SS, van Berge Henegouwen MI, Maas KW, et al. Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial. Lancet (London, England). 2012;379(9829):1887–92.CrossRef
12.
Li C, Ferri LE, Mulder DS, et al. An enhanced recovery pathway decreases duration of stay after esophagectomy. Surgery. 2012;152(4):606–14 (discussion 14–6).CrossRefPubMed
13.
Weijs TJ, Dieleman JM, Ruurda JP, et al. The effect of perioperative administration of glucocorticoids on pulmonary complications after transthoracic oesophagectomy: a systematic review and meta-analysis. Eur J Anaesthesiol. 2014;31(12):685–94.CrossRefPubMed
14.
Shimizu K, Ogura H, Goto M, et al. Altered gut flora and environment in patients with severe SIRS. J Trauma. 2006;60(1):126–33.CrossRefPubMed
15.
Wiest R, Garcia-Tsao G. Bacterial translocation (BT) in cirrhosis. Hepatology (Baltimore, Md). 2005;41(3):422–33.CrossRef
16.
Deitch EA, Bridges RM. Effect of stress and trauma on bacterial translocation from the gut. J Surg Res. 1987;42(5):536–42.CrossRefPubMed
17.
Mizuno T, Yokoyama Y, Nishio H, et al. Intraoperative bacterial translocation detected by bacterium-specific ribosomal rna-targeted reverse-transcriptase polymerase chain reaction for the mesenteric lymph node strongly predicts postoperative infectious complications after major hepatectomy for biliary malignancies. Ann Surg. 2010;252(6):1013–9.CrossRefPubMed
18.
Nishigaki E, Abe T, Yokoyama Y, et al. The detection of intraoperative bacterial translocation in the mesenteric lymph nodes is useful in predicting patients at high risk for postoperative infectious complications after esophagectomy. Ann Surg. 2014;259(3):477–84.CrossRefPubMed
19.
Takechi H, Mawatari K, Harada N, et al. Glutamine protects the small intestinal mucosa in anticancer drug-induced rat enteritis model. J Med Investig (JMI). 2014;61(1–2):59–64.CrossRef
20.
van der Hulst RR, von Meyenfeldt MF, Tiebosch A, et al. Glutamine and intestinal immune cells in humans. JPEN J Parenter Enter Nutr. 1997;21(6):310–5.CrossRef
21.
Chun H, Sasaki M, Fujiyama Y, et al. Effect of enteral glutamine on intestinal permeability and bacterial translocation after abdominal radiation injury in rats. J Gastroenterol. 1997;32(2):189–95.CrossRefPubMed
22.
Hardy H, Harris J, Lyon E, et al. Probiotics, prebiotics and immunomodulation of gut mucosal defences: homeostasis and immunopathology. Nutrients. 2013;5(6):1869–912.CrossRefPubMedPubMedCentral
23.
Rice TW, Rusch VW, Ishwaran H, et al. Cancer of the esophagus and esophagogastric junction: data-driven staging for the seventh edition of the American Joint Committee on Cancer/International Union Against Cancer Staging Manuals. Cancer. 2010;116(16):3763–73.CrossRefPubMed
24.
Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205–13.CrossRefPubMedPubMedCentral
25.
Joo E, Muraoka A, Hamasaki A, et al. Enteral supplementation with glutamine, fiber, and oligosaccharide modulates incretin and glucagon-like peptide-2 secretion. J Diabetes Investig. 2015;6(3):302–8.CrossRefPubMed
26.
Iyama S, Sato T, Tatsumi H, et al. Efficacy of enteral supplementation enriched with glutamine, fiber, and oligosaccharide on mucosal injury following hematopoietic stem cell transplantation. Case Rep Oncol. 2014;7(3):692–9.CrossRefPubMedPubMedCentral
27.
Higashiguchi TIA, Futamura A, Kodama Y, et al. Effects of GFO on the pathological and functional changes in the intestinal mucosa associated with total parenteral nutrition in rats. Jpn J Surg Metab Nutr. 2009;43:51–60.
28.
Marton S, Ghosh S, Papp A, et al. Effect of glutamine in patients with esophagus resection. Dis Esophagus. 2010;23(2):106–11.CrossRefPubMed
29.
van Zanten AR, Dhaliwal R, Garrel D, et al. Enteral glutamine supplementation in critically ill patients: a systematic review and meta-analysis. Crit Care. 2015;19:294.CrossRefPubMedPubMedCentral
30.
Gibson GR, Roberfroid MB. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr. 1995;125(6):1401–12.CrossRefPubMed
31.
Sugawara G, Nagino M, Nishio H, et al. Perioperative synbiotic treatment to prevent postoperative infectious complications in biliary cancer surgery: a randomized controlled trial. Ann Surg. 2006;244(5):706–14.CrossRefPubMedPubMedCentral
32.
Tanaka K, Yano M, Motoori M, et al. Impact of perioperative administration of synbiotics in patients with esophageal cancer undergoing esophagectomy: a prospective randomized controlled trial. Surgery. 2012;152(5):832–42.CrossRefPubMed
33.
Yokoyama Y, Nishigaki E, Abe T, et al. Randomized clinical trial of the effect of perioperative synbiotics versus no synbiotics on bacterial translocation after oesophagectomy. Br J Surg. 2014;101(3):189–99.CrossRefPubMed
34.
Reddy BS, Macfie J, Gatt M, et al. Randomized clinical trial of effect of synbiotics, neomycin and mechanical bowel preparation on intestinal barrier function in patients undergoing colectomy. Br J Surg. 2007;94(5):546–54.CrossRefPubMed
35.
Eguchi S, Takatsuki M, Hidaka M, et al. Perioperative synbiotic treatment to prevent infectious complications in patients after elective living donor liver transplantation: a prospective randomized study. Am J Surg. 2011;201(4):498–502.CrossRefPubMed
Metadata
Title
Perioperative enteral supplementation with glutamine, fiber, and oligosaccharide reduces early postoperative surgical stress following esophagectomy for esophageal cancer
Authors
Tetsuya Abe
Takahiro Hosoi
Ryosuke Kawai
Norihisa Uemura
Eiji Higaki
Byonggu An
Jiro Kawakami
Takuya Saito
Yasuhiro Shimizu
Publication date
01-01-2019
Publisher
Springer Singapore
Published in
Esophagus / Issue 1/2019
Print ISSN: 1612-9059
Electronic ISSN: 1612-9067
DOI
https://doi.org/10.1007/s10388-018-0630-z

Other articles of this Issue 1/2019

Esophagus 1/2019 Go to the issue

Review Article

Interactions between Helicobacter pylori and gastroesophageal reflux disease

Original Article

A new esophageal elongation technique for long-gap esophageal atresia: in vitro comparison of myotomy techniques

Original Article

Inter-institutional variations regarding Barrett’s esophagus diagnosis

Original Article

Robot-assisted mediastinoscopic esophagectomy for esophageal cancer: the first clinical series

Review Article

Observation of the cytoarchitecture of the human esophageal mucosa with special attention to the lamina muscularis mucosae and the distribution of lymphatic vessels

Special Article

Esophageal cancer practice guidelines 2017 edited by the Japan Esophageal Society: part 1
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits